Home / Market News / $PHR

$PHR news and market catalysts

The 8 most recent market catalysts affecting $PHR, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

8 catalysts 1 high impact 2 bullish 3 bearish Healthcare Technology
Sep 8, 2026 Corporate Catalyst Bearish Impact 55
Raymond James Downgrades Phreesia to Market Perform
Raymond James analyst John Ransom downgraded Phreesia (PHR) from Outperform to Market Perform. This action indicates that the analyst no longer believes the stock will outperform t…
Sep 3, 2026 Corporate Catalyst Neutral Impact 65
Phreesia Files Shelf Prospectus For Offering; Size Not Disclosed
Phreesia (PHR) has filed a shelf prospectus, which is a registration statement allowing a company to offer and sell securities to the public over an extended period without filing …
Sep 3, 2026 Corporate Catalyst Bearish Impact 75
These Analysts Revise Their Forecasts On Phreesia After Q2 Results
Phreesia Inc. (PHR) announced Q2 earnings that missed analyst consensus on EPS but beat on revenue. Despite the revenue beat and affirmed FY2027 guidance, the EPS miss likely contr…
Sep 2, 2026 Corporate Catalyst Neutral Impact 75
Transcript: Phreesia Q2 2027 Earnings Conference Call
Phreesia's Q2 2027 earnings report reveals a 10% year-over-year revenue increase to $129.5 million and a positive net income of $1.9 million, marking its fifth consecutive profitab…
Sep 2, 2026 Market Technicals Bullish Impact 55
12 Health Care Stocks Moving In Wednesday's After-Market Session
This filing details the after-market performance of several health care stocks, with some experiencing substantial gains and others significant losses. The movements are likely a r…
Sep 2, 2026 Corporate Catalyst Bearish Impact 75
Phreesia shares are trading lower after the company reported mixed Q2 financial results.
The headline signals a significant corporate catalyst for Phreesia (PHR). While an earnings beat is positive, the lower revenue guidance for Q3 and the full year is a major red fla…
Sep 2, 2026 Corporate Catalyst Bullish Impact 92
Phreesia Q2 EPS $0.03 Misses $0.10 Estimate, Sales $129.458M Beat $129.069M Estimate
Phreesia (PHR) announced its Q2 earnings, revealing a substantial miss on earnings per share ($0.03 actual vs. $0.10 estimate), representing a 70% shortfall. This is a critical pie…
Aug 31, 2026 Corporate Catalyst Neutral Impact 55
Needham Reiterates Buy on Phreesia, Maintains $14 Price Target
Needham analyst Ryan MacDonald has reiterated a 'Buy' rating on Phreesia (PHR) and maintained a $14 price target. This action signals continued analyst conviction in the company's …
 Join the waitlist for full signal validation →

New to reading filings? What an SEC 8-K is and why it moves prices

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.